Page last updated: 2024-11-06

tyrosine methyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tyrosine methyl ester (TME) is a derivative of the amino acid tyrosine, where the carboxyl group has been esterified with methanol. TME is often used as a building block in the synthesis of peptides and other biologically active compounds. It is also studied for its potential therapeutic properties, including its ability to modulate neurotransmitter release and its antioxidant activity. The methylation of tyrosine is a common modification in peptides and proteins. TME is a relatively simple compound that can be readily synthesized, making it a useful tool for studying the effects of tyrosine methylation. The esterification of tyrosine increases its lipophilicity, which may allow it to penetrate cell membranes more easily. It is often used as a model system to study the effects of tyrosine methylation on protein-protein interactions and enzyme activity.'

tyrosine methyl ester: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

methyl L-tyrosinate : An L-tyrosyl ester that is the methyl ester of L-tyrosine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID70652
CHEMBL ID300797
CHEBI ID17215
SCHEMBL ID314923
MeSH IDM0120428

Synonyms (54)

Synonym
l-tyrosine, methyl ester
CHEBI:17215 ,
methyl l-tyrosinate
2-amino-3-(4-hydroxy-phenyl)-propionic acid methyl ester
tyr-ome
tyrosine methyl ester
(s)-2-amino-3-(4-hydroxy-phenyl)-propionic acid methyl ester
1080-06-4
l-tyrosine methyl ester
C03404
l-tyrosine methyl ester, 98%
MLS000028636
smr000059192
NCGC00018273-01
T-9340
AKOS000302242
CHEMBL300797
methyl (2s)-2-amino-3-(4-hydroxyphenyl)propanoate
A801791
T2736
h-tyr-ome
HMS2231K24
AKOS010395402
einecs 214-095-3
wr2xy2y23p ,
unii-wr2xy2y23p
ccris 4038
BP-12562
tyrosine, methyl ester
(s)-methyl 2-amino-3-(4-hydroxyphenyl)propanoate
SCHEMBL314923
(l)-tyrosine methyl ester
methyl (s)-2-amino-3-(4-hydroxyphenyl)propionate
(2s)-amino-3-(4-hydroxy-phenyl)-propionic acid methyl ester
methyl tyrosinate
l-tyrosine methy lester
(s)-tyrosine methyl ester
J-300282
methyl 2-amino-3-(4-hydroxyphenyl)propanoate #
tyrosine, methyl ester, l-
DTXSID40148354
CS-W007671
(s)-2-amino-3-(4-hydroxyphenyl)propionic acid methyl ester
mfcd00002392
tyrosine methylester
DS-14401
Q27102267
M03107
HY-W007671
s-tyrosine methyl ester
methyl (s)-2-amino-3-(4-hydroxyphenyl)propanoate
methyl (2s)-2-amino-3-(4-hydroxyphenyl)propionate
methyl (2s)-3-(4-hydroxyphenyl)-2-aminopropionate
EN300-7365559

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Our results suggest that L-valine is a desirable L-amino acid for the esterification of poorly permeable drugs to enhance their oral bioavailability targeting intestinal PEPT1."( Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.
Hashimoto, Y; Inui, KI; Saito, H; Sawada, K; Terada, T, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
L-tyrosyl esterAn alpha-amino acid ester resulting from esterification of the carboxy group of L-tyrosine.
methyl esterAny carboxylic ester resulting from the formal condensation of a carboxy group with methanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency3.16230.044717.8581100.0000AID485294
survival motor neuron protein isoform dHomo sapiens (human)Potency0.89130.125912.234435.4813AID1458
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sulfotransferase 1A1 Rattus norvegicus (Norway rat)Km4,000.00005.00007.571410.0000AID39219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID681161TP_TRANSPORTER: inhibition of L-tryptophan uptake in Xenopus laevis oocytes2002Genomics, Jan, Volume: 79, Issue:1
The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location.
AID39219Apparent Michaelis constant (Km) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID494523Antileishmanial activity against Leishmania donovani promastigotes after 48 hrs by MTT assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis and antileishmanial activity of piperoyl-amino acid conjugates.
AID494524Cytotoxicity against human PBMC at IC50 concentration after 48 hrs by MTT assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis and antileishmanial activity of piperoyl-amino acid conjugates.
AID350218Octanol-water partition coefficient, log PC of the compound2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
AID494525Cytotoxicity against human PBMC at 2 times IC50 concentration after 48 hrs by MTT assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis and antileishmanial activity of piperoyl-amino acid conjugates.
AID350219Lipophilicity, log K at pH 2 by by hydrophilic interaction chromatography using 95% acetonitrile as mobile phase2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
AID26797Partition coefficient (logP)1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Quantitative structure-activity relationships of the bitter thresholds of amino acids, peptides, and their derivatives.
AID494522Antileishmanial activity against Leishmania donovani amastigotes after 48 hrs by MTT assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis and antileishmanial activity of piperoyl-amino acid conjugates.
AID229377Ratio of kcat/Km determined for catalytic efficiency in sulfonation against AST IV2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID39220Maximal velocity (Vmax) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID681113TP_TRANSPORTER: inhibition of L-tryptophan uptake in Xenopus laevis oocytes2001The Journal of biological chemistry, May-18, Volume: 276, Issue:20
Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters.
AID233318Bitter threshold value1987Journal of medicinal chemistry, Oct, Volume: 30, Issue:10
Quantitative structure-activity relationships of the bitter thresholds of amino acids, peptides, and their derivatives.
AID350220Lipophilicity, log K at pH 2 by by hydrophilic interaction chromatography using 100% water as mobile phase2009Journal of medicinal chemistry, May-28, Volume: 52, Issue:10
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
AID678873TP_TRANSPORTER: inhibition of Gly-Sar uptake (Gly-Sar: 20 uM, Tyr-OMe: 10000 uM) in PEPT2-expressing LLC-PK1 cells1999The Journal of pharmacology and experimental therapeutics, Nov, Volume: 291, Issue:2
Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (14.29)18.7374
1990's8 (28.57)18.2507
2000's7 (25.00)29.6817
2010's9 (32.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.26 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index32.99 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (22.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]